Concert Wealth Management’s Applied Materials AMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-27,188
Closed -$882K – 165
2017
Q1
$882K Sell
27,188
-351
-1% -$12.6K 0.2% 145
2016
Q4
$894K Sell
27,539
-13,429
-33% -$409K 0.2% 146
2016
Q3
$1.24M Sell
40,968
-2,141
-5% -$59.7K 0.15% 172
2016
Q2
$1.03M Buy
43,109
+3,024
+8% +$66.7K 0.14% 199
2016
Q1
$855K Buy
40,085
+487
+1% +$8.88K 0.11% 224
2015
Q4
$741K Sell
39,598
-1,645
-4% -$28.6K 0.1% 259
2015
Q3
$607K Sell
41,243
-267
-0.6% -$4.46K 0.08% 307
2015
Q2
$797K Sell
41,510
-3,726
-8% -$76.5K 0.1% 255
2015
Q1
$574K Buy
45,236
+538
+1% +$12.9K 0.16% 178
2014
Q4
$1.11M Buy
44,698
+9,247
+26% +$209K 0.17% 158
2014
Q3
$765K Buy
35,451
+1,091
+3% +$24.1K 0.1% 188
2014
Q2
$729K Buy
34,360
+1,774
+5% +$36.2K 0.09% 202
2014
Q1
$659K Buy
+32,586
New +$598K 0.08% 214
2013
Q4
– Sell
-35,588
Closed -$619K – 534
2013
Q3
$619K Buy
35,588
+12,655
+55% +$202K 0.09% 213
2013
Q2
$343K Buy
+22,933
New +$333K 0.05% 303

Other funds holding AMAT

Concert Wealth Management's AMAT Position: Q2 2017 in Review

Concert Wealth Management sold out of Applied Materials (AMAT) in Q2 2017, closing a stake of 27,188 shares — an estimated $882K sold.

Concert Wealth Management first reported a position in AMAT in Q2 2013 and held it in 15 quarters. The position peaked at $1.24M in Q3 2016. 940 funds tracked by Wall St. Rank hold AMAT as of Q2 2017.

  • Concert Wealth Management reported no remaining Applied Materials position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 27,188 Applied Materials shares in Q2 2017, an estimated $882K.
  • Concert Wealth Management first reported a position in Applied Materials in Q2 2013 and held it in 15 quarters.
  • Concert Wealth Management's Applied Materials position peaked at $1.24M in Q3 2016.
  • 940 funds tracked by Wall St. Rank held Applied Materials as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.